Delivery Order SPE2DB22D3016-SPE2DB25FAJB2

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Esomeprazole Magnesium Delayed-Release capsules. The $1,506.76 firm fixed-price delivery order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $99,593.73, is for the delivery of Esomeprazole 40mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This federal contract award, valued at $1,562.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the delivery of ESOMEPRAZOLE MAG DR 20 MG CAP 90S, a medication used to treat acid-related disorders....
This federal contract award was issued by the Medical Supply Chain, a division of the Defense Logistics Agency (DLA) Troop Support, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,218.78, is for the delivery of 4564840055 - ESOMEPRAZOLE MAG DR 40 MG CAP 90S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of June 10, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a...
This federal contract award, valued at $90,051.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,769.94 firm fixed-price delivery order is for the supply of Nexium DR 40 mg capsules. The contract has an ultimate completion date of April 13, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,294.18 Firm Fixed Price delivery order is for the provision of 4560924039 Nexium DR 40 MG Capsule 90S, with a period of performance through May 15, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,434.70 for the supply of NEXIUM DR 20 MG PACKET 30S, a prescription drug product. The contract has an ultimate completion date of November 22, 2024. This appears to be a call-order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, with ID SPE2DB20D3101|SPE2DB21FK4B4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,032.28 firm fixed-price delivery order is for the supply of Esomeprazole Magnesium Delayed-Release 40mg capsules. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order under contract SPE2DX15D1053|SPE2DX24F6TWB, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,101.55 firm fixed-price contract is for the delivery of esomeprazole magnesium delayed-release 40 mg capsules in 30-count packages. This order is not set aside for any small business program. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAJB2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,319.56, is for the delivery of esomeprazole delayed-release packets in support of federal healthcare programs.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/6/25, 12:45 AM